Changchun High-Tech Industry (Group) Co., Ltd. (SHE:000661)

Market Cap	28.88B -44.9%
Revenue (ttm)	11.02B -17.9%
Net Income	-352.58M
EPS	-0.89
Shares Out	401.71M
PE Ratio	n/a
Forward PE	26.78
Dividend	0.16 (0.22%)
Ex-Dividend Date	May 25, 2026

Volume	6,329,698
Open	70.56
Previous Close	69.23
Day's Range	68.28 - 72.20
52-Week Range	61.09 - 141.77
Beta	0.34
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2026

About SHE:000661

Changchun High-Tech Industry (Group) Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells biopharmaceuticals and traditional Chinese medicines products in China. The company offers recombinant human growth hormone injection; recombinant human follicle stimulating hormone for injection; herpes zoster vaccines; live attenuated varicella vaccine; freeze-dried nasal spray live attenuated influenza; xueshuanxinmaining tablet; and yinhuamiyanling tablet. It also develops real estate properties. The company was foun...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 10,080
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000661

Financial Performance

In 2025, SHE:000661's revenue was 12.08 billion, a decrease of -10.27% compared to the previous year's 13.47 billion. Earnings were 154.97 million, a decrease of -94.00%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 9, 2026

Data Sources Report a data error